VEGFA and peripheral arterial disease: However, some conflicting clinical data with regard to the upregulation of antiangiogenic VEGF-A165b have been collected; serum VEGF-A165b is elevated with peripheral arterial disease but reduced in patients with critical limb ischemia relative to those with intermittent claudication or normal blood flow [23,24,25].